In Vitro and In Vivo Evaluation of Carboplatin Delivery to the Eye Using Hydrogel-Iontophoresis

REFERENCES

• Baeyens V, Percicot C, Zignani M, Deshpande A A, Kaltsatos V, Gurny R. Ocular drug delivery in veterinary medicine. Adv Drug Deliv Rev 1997; 28: 335–361
   PubMed Web of Science ®Google Scholar
• Guy R H, Kalia Y N, Delgado-Charro M B, Merino V, Lopez A, Marro D. Iontophoresis: Electrorepulsion and electroosmosis. J Control Release 2000; 64: 129–132
   PubMed Web of Science ®Google Scholar
• Eljarrat-Binstock E, Domb A J. Iontophoresis: A non-invasive ocular drug delivery. J Control Release 2006; 110: 479–489
   PubMed Web of Science ®Google Scholar
• Bridger M W, Keene M, Graham J M, Healey R, Ammar M M. A device for iontophoretic anesthesia of the tympanic membrane. J Med Eng Technol 1982; 6: 62–64
   PubMed Web of Science ®Google Scholar
• Zempsky W T, Sullivan J, Paulson D M, Hoath S B. Evaluation of a low-dose lidocaine iontophoresis system for topical anesthesia in adults and children: A randomized controlled trial. Clin Ther 2004; 26: 1110–1119
   PubMed Web of Science ®Google Scholar
• Moppett I K, Szypula K, Yeoman P M. Comparison of Emla and lidocaine iontophoresis for cannulation analgesia. Eur J Anaesthesiol 2004; 21: 210–213
   PubMed Web of Science ®Google Scholar
• DeCou J M, Abrams R S, Hammond J H, Lowder L R, Gauderer M WL. Iontophoresis: A needle-free electrical system of local anesthesia delivery for pediatric surgical office procedures. J Pediatr Surg 1999; 34: 946–949
   PubMed Web of Science ®Google Scholar
• Gibson L E, Cooke R E. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959; 23: 545–549
   PubMed Web of Science ®Google Scholar
• Carter E P, Barrett A D, Heeley A F, Kuzemko J A. Improved sweat test method for the diagnosis of cystic fibrosis. Arch Dis Child 1984; 59: 919–922
   PubMed Web of Science ®Google Scholar
• Gangarosa L P, Hill J M, Thompson B L, Leggett C, Rissing J P. Iontophoresis of vidarabine monophosphate for herpes orolabialis. J Infect Dis 1986; 154: 930–934
   PubMed Web of Science ®Google Scholar
• Gangarosa L P, Park N H. Practical considerations in iontophoresis of fluoride for desensitizing dentine. J Prosthet Dent 1978; 39: 173–178
   PubMed Web of Science ®Google Scholar
• Krauser J T. Hypersensitive teeth. Part Ii: Treatment. J Prosthet Dent 1986; 56: 307–311
   PubMed Web of Science ®Google Scholar
• Barza M, Peckman C, Baum J. Transscleral iontophoresis of cefazolin, ticarcillin, and gentamicin in the rabbit. Ophthalmology 1986; 93: 133–139
   PubMed Web of Science ®Google Scholar
• Frucht-Pery J, Goren D, Solomon A, et al. The distribution of gentamicin in the rabbit cornea following iontophoresis to the central cornea. J Ocul Pharmacol Ther 1999; 15: 251–256
   PubMed Web of Science ®Google Scholar
• Rootman D S, Hobden J A, Jantzen J A, Gonzalez J R, Ocallaghan R J, Hill J M. Iontophoresis of tobramycin for the treatment of experimental pseudomonas keratitis in the rabbit. Arch Ophthalmol 1988; 106: 262–265
   PubMed Web of Science ®Google Scholar
• Yoshizumi M O, Cohen D, Verbukh I, Leinwand M, Kim J, Lee D A. Experimental transscleral iontophoresis of ciprofloxacin. J Ocular Pharmacol 1991; 7: 163–167
   PubMedGoogle Scholar
• Eljarrat-Binstock E, Raiskup F, Stepensky D, Domb A J, Frucht-Pery J. Delivery of gentamicin to the rabbit eye by drug-loaded hydrogel iontophoresis. Invest Ophthalmol Vis Sci 2004; 45: 2543–2548
   PubMed Web of Science ®Google Scholar
• Lam T T, Fu J, Chu R, Stojack K, Siew E, Tso M OM. Intravitreal delivery of ganciclovir in rabbits by transscleral iontophoresis. J Ocul Pharmacol 1994; 10: 571–575
   PubMedGoogle Scholar
• Behar-Cohen F F, El Aouni A, Gautier S, et al. Transscleral coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: Influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels. Exp Eye Res 2002; 74: 51–59
   PubMed Web of Science ®Google Scholar
• Behar-Cohen F F, Parel J M, Pouliquen Y, et al. Iontophoresis of dexamethasone in the treatment of endotoxin-induced uveitis in rats. Exp Eye Res 1997; 65: 533–545
   PubMed Web of Science ®Google Scholar
• Eljarrat-Binstock E, Raiskup F, Frucht-Pery J, Domb A J. Transcorneal and transscleral iontophoresis of dexamethasone phosphate using drug-loaded hydrogel. J Control Release 2005; 106: 386–390
   PubMed Web of Science ®Google Scholar
• Hayden B C, Jockovich M E, Murray T G, et al. Pharmacokinetics of systemic versus focal carboplatin chemotherapy in the rabbit eye: Possible implication in the treatment of retinoblastoma. Invest Ophthalmol Vis Sci 2004; 45: 3644–3649
   PubMed Web of Science ®Google Scholar
• Kondo M, Araie M. Iontophoresis of 5-fluorouracil into the conjunctiva and sclera. Invest Ophthalmol Vis Sci 1989; 30: 583–585
   PubMed Web of Science ®Google Scholar
• Asahara T, Shinomiya K, Naito T, Shiota H. Induction of gene into the rabbit eye by iontophoresis: Preliminary report. Jpn J Ophthalmol 2001; 45: 31–39
   PubMed Web of Science ®Google Scholar
• Abramson D H, Frank C M, Chantada G L, et al. Intraocular carboplatin concentrations following intravenous administration for human intraocular retinoblastoma. Ophthalmic Genet 1999; 20: 31–36
   PubMedGoogle Scholar
• Harbour J W, Murray T G, Hamasaki D, et al. Local carboplatin therapy in transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci 1996; 37: 1892–1898
   PubMed Web of Science ®Google Scholar
• Murray T G, Roth D B, O'Brien J M, et al. Local carboplatin and radiation therapy in the treatment of murine transgenic retinoblastoma. Arch Ophthalmol 1996; 114: 1385–1389
   PubMed Web of Science ®Google Scholar
• Murray T G, Cicciarelli N, Obrien J M, et al. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma. Arch Ophthalmol 1997; 115: 1286–1290
   PubMed Web of Science ®Google Scholar
• Mendelsohn M E, Abramson D H, Madden T, Tong W, Tran H T, Dunkel I J. Intraocular concentrations of chemotherapeutic agents after systemic or local administration. Arch Ophthalmol 1998; 116: 1209–1212
   PubMed Web of Science ®Google Scholar
• Hayden B H, Murray T G, Scott I U, et al. Subconjunctival carboplatin in retinoblastoma—impact of tumor burden and dose schedule. Arch Ophthalmol 2000; 118: 1549–1554
   PubMedGoogle Scholar
• Abramson D H, Frank C M, Dunkel I J. A phase I/Ii study of subconjunctival carboplatin for intraocular retinoblastoma. Ophthalmology 1999; 106: 1947–1950
   PubMed Web of Science ®Google Scholar
• Pardue M T, Hejny C, Gilbert J A, Phillips M J, Geroski D H, Edelhauser H F. Retinal function after subconjunctival injection of carboplatin in fibrin sealant. Retin—J Retin Vitr Dis 2004; 24: 776–782
   PubMed Web of Science ®Google Scholar
• Van Quill K R, Dioguardi P K, Tong C T, et al. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma. Ophthalmology 2005; 112: 1151–1158
   PubMed Web of Science ®Google Scholar
• Mulvihill A, Budning A, Jay V, et al. Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma. Arch Ophthalmol 2003; 121: 1120–1124
   PubMed Web of Science ®Google Scholar
• Hayden B, Jockovich M E, Murray T G, et al. Iontophoretic delivery of carboplatin in a murine model of retinoblastoma. Invest Ophthalmol Vis Sci 2006; 47: 3717–3721
   PubMed Web of Science ®Google Scholar
• Alvarez–Figueroa M J, Blanco-Mendez J. Transdermal delivery of methotrexate: Iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int J Pharm 2001; 215: 57–65
   PubMed Web of Science ®Google Scholar
• Banga A K, Chien Y W. Hydrogel-based iontotherapeutic delivery devices for transdermal delivery of peptide/protein drugs. Pharm Res 1993; 10: 697–702
   PubMed Web of Science ®Google Scholar
• Fischer G A, Parkinson T M, Szlek M A. OcuPhor—The future of ocular drug delivery. Drug Delivery Tech 2002; 2: 50–52
   Google Scholar
• Vollmer D L, Szlek M A, Kolb K, Lloyd L B, Parkinson T M. In vivo transscleral iontophoresis of amikacin to rabbit eyes. J Ocul Pharmacol Ther 2002; 18: 549–558
   PubMed Web of Science ®Google Scholar
• Hastings M S, Li S K, Miller D J, Bernstein P S, Mufson D. Visulex: Advancing iontophoresis for effective noninvasive back-to-the-eye therapeutics. Drug Delivery Tech 2004; 4: 53–57
   Google Scholar
• Eljarrat-Binstock E, Raiskup F, Frucht-Pery J, Domb A J. Hydrogel probe for iontophoresis drug delivery to the eye. J Biomater Sci Polym Ed 2004; 15: 397–413
   PubMed Web of Science ®Google Scholar
• Frucht-Pery J, Mechoulam H, Siganos C S, Ever-Hadani P, Shapiro M, Domb A. Iontophoresis-gentamicin delivery into the rabbit cornea using a hydrogel delivery probe. Exp Eye Res 2004; 78: 745–749
   PubMed Web of Science ®Google Scholar
• Pohlen U, Rieger H, Meyer B T, et al. Chemoembolization of lung metastases—pharmacokinetic behaviour of carboplatin in a rat model. Anticancer Res 2007; 27: 809–815
   PubMed Web of Science ®Google Scholar
• Brouneus F, Karami K, Beronius P, Sundelof L O. Diffusive transport properties of some local anesthetics applicable for iontophoretic formulation of the drugs. Int J Pharm 2001; 218: 57–62
   PubMed Web of Science ®Google Scholar
• Anderson C R, Morris R L, Boeh S D, Panus P C, Sembrowich W L. Effects of iontophoresis current magnitude and duration on dexamethasone deposition and localized drug retention. Phys Ther 2003; 83: 161–170
   PubMed Web of Science ®Google Scholar
• Wilson T W, Chan H SL, Moselhy G M, Heydt D D, Frey C M, Gallie B L. Penetration of chemotherapy into vitreous is increased by cryotherapy and cyclosporine rabbits. Arch Ophthalmol 1996; 114: 1390–1395
   PubMed Web of Science ®Google Scholar
• Zlioba A, Peyman G A, Nikoleit J. Retinal toxicity study of intravitreal carboplatin and iproplatin. Ann Ophthalmol 1988; 20: 71–72
   PubMedGoogle Scholar
• Eljarrat-Binstock E, Domb A J, Orucov F, Frucht-Pery J, Pe'er J. Methotrexate delivery to the eye using transscleral hydrogel iontophoresis. Curr Eye Res 2007; 32: 639–646
   PubMed Web of Science ®Google Scholar
• Eljarrat-Binstock E, Orucov F, Frucht-Pery J, Pe'er J, Domb A J. Methylprednisolone delivery to the back of the eye using hydrogel iontophoresis. J Ocular Pharm Ther 2008, In press
   PubMed Web of Science ®Google Scholar
• Eljarrat-Binstock E, Orucov F, Aldouby Y, Frucht-Pery J, Domb A J. Charged nonoparticles delivery to the eye using hydrogel iontophoresis. J Control Release 2008; 126: 156–161
   PubMed Web of Science ®Google Scholar
• Eljarrat-Binstock E, Bentolila A, Kumar N, Harel H, Domb A. Preparation, characterization and sterilization of hydrogel sponges for iontophoretic drug-delivery use. Polym Adv Tech 2007; 18: 720–730
   Web of Science ®Google Scholar
• Simpson A E, Gilbert J A, Rudnick D E, Geroski D H, Aberg T M, Edelhauser H F. Transscleral diffusion of carboplatin—an in vitro and in vivo study. Arch Ophthalmol 2002; 120: 1069–1074
   PubMed Web of Science ®Google Scholar
• Boulikas T, Vougiouka M. Cisplatin and platinum drugs at the molecular level. Oncology Reports 2003; 10: 1663–1682
   PubMed Web of Science ®Google Scholar